Equity
€200,669 ▼ 19.8%
DR DECLEYRE-BADIU paid out €108,240 in dividends. That is 184% of the 2025 profit.
DR DECLEYRE-BADIU
Lifetime
17 annual accounts with figures on one time axisGross marginpeak €214,805 (2012)
€127,224▼ 27.3%
Resultpeak €81,688 (2024)
€58,835▼ 28.0%
Equitypeak €378,558 (2017)
€200,669▼ 19.8%
Debts
€88,400▼ 23.9%
Board2 names since 2008
2 directorsDECLEYRE-BADIU and 1 other
Owners
Documentsfilings and deeds
05-08-20265 days late
2025micro format
Gross margin from €175,059 to €127,224Result from €81,688 to €58,835Dividend €108,240Equity from €250,074 to €200,669Debts from €116,094 to €88,400
Key points
from the 2025 annual accountsChecked score
92
Excellent
Financially stronger than 46% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.3%
01-2025: 0.4%▲ +0.1 percentage points vs 12-2024
02-2025: 0.7%▲ +0.3 percentage points vs 01-2025
03-2025: 0.9%▲ +0.2 percentage points vs 02-2025
04-2025: 1.7%▲ +0.8 percentage points vs 03-2025
05-2025: 1.8%▲ +0.1 percentage points vs 04-2025
06-2025: 2.5%▲ +0.7 percentage points vs 05-2025
07-2025: 3.9%▲ +1.4 percentage points vs 06-2025highest value
08-2025: 3.9%● unchanged vs 07-2025highest value
09-2025: 0.4%▼ -3.5 percentage points vs 08-2025
10-2025: 0.4%● unchanged vs 09-2025
11-2025: 0.4%● unchanged vs 10-2025
12-2025: 0.4%● unchanged vs 11-2025
01-2026: 0.5%▲ +0.1 percentage points vs 12-2025
02-2026: 0.5%● unchanged vs 01-2026
03-2026: 0.5%● unchanged vs 02-2026
04-2026: 0.5%● unchanged vs 03-2026
05-2026: 0.1%▼ -0.4 percentage points vs 04-2026lowest value
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.3%▲ +0.2 percentage points vs 07-2026
09-2026: 0.1%▼ -0.2 percentage points vs 08-2026
10-2026: 0.1%● unchanged vs 09-2026
11-2026: 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Profit of €58,835 (financial year 2025)
lowers risk
Size: total assets €289,069
Founded in 2008
Figures for financial year 2025 (filed on 06-08-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 58% of them on solvency, 33% on liquidity, 76% on profitability and 18% on growth.
The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 34,693 companies had the same profile as DR DECLEYRE-BADIU has now. Each dot stands for 87 companies, two years later.
95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of DR DECLEYRE-BADIU itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,693 companies, not a prediction for DR DECLEYRE-BADIU. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €18,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.89 (4.16 in 2024), above the usual 1.5. Short-term debt is 19.5% and cash 4.7% of total assets. 30.6% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 5 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-08-2026, 5 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
5 days late
2024
3 days late
2023
48 days early
2022
43 days early
2021
4 days early
2020
2 days early
2019
9 days early
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 7 accounts on average 14 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0806251231
Changes of role: DECLEYRE-BADIU (director) and DECLEYRE Bruno René Simon Henri François Léon (director)
Registered office clause: Walloon Region · Director discharge: DECLEYRE-BADIU · Director discharge: DECLEYRE Bruno René Simon Henri François Léon · General meeting of 22-12-2023 · Gazette deed
Incorporation
published on 18-09-2008 · Gazette deed
First establishment
Rue du Rivage 80, Tournai
Official details
Source: KBO- Status
- Active since 10-09-2008Normal situation
- Activity
- “Gestion en bon père de famille sans caractère répétitif et commercial” (deed in French)From the articles, 8 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.215.800.5937540 Tournai, since 29-08-2008
- Financial year end
- 31 December
- Peppol
- Reachable since 04-11-2025
Insights on DR DECLEYRE-BADIU
DR DECLEYRE-BADIU files the micro format. That format states no turnover. The gross margin rose from €65,579 in 2009 to €127,224 in 2025.
The balance sheet grew most from 2011 to 2013 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR DECLEYRE-BADIU
- What is the company number of DR DECLEYRE-BADIU?
- The company number of DR DECLEYRE-BADIU is 0806.251.231. The VAT number is the same number with BE in front: BE 0806.251.231.
- Where is DR DECLEYRE-BADIU based?
- The registered office is at Antonio Vivaldilaan 23, 7712 Mouscron.Company details
- What is the legal form of DR DECLEYRE-BADIU?
- DR DECLEYRE-BADIU is a private limited company (BV).
- When was DR DECLEYRE-BADIU founded?
- DR DECLEYRE-BADIU was founded on 10-09-2008.
- Is DR DECLEYRE-BADIU still active?
- Yes, DR DECLEYRE-BADIU is an active enterprise in the KBO register.
- What is the turnover of DR DECLEYRE-BADIU?
- The turnover in financial year 2025 is ≈ €320,000. This figure is estimated from the gross margin of €127,224 and 2,216 comparable companies of the same size. It probably lies between €210,000 and €490,000. It is a rough estimate.Financials
- Is DR DECLEYRE-BADIU profitable?
- In financial year 2025, DR DECLEYRE-BADIU made a profit of €58,835.
- Where can I find the annual accounts of DR DECLEYRE-BADIU?
- DR DECLEYRE-BADIU filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR DECLEYRE-BADIU due?
- DR DECLEYRE-BADIU must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.